borderline significancep = 0.048
A borderline significance was noted in developing MACE in younger patients (aged 45–64 years; adjusted HR 1.12; 95% CI 1.00–1.26; p = 0.048).
A borderline significance was noted in developing MACE in younger patients (aged 45–64 years; adjusted HR 1.12; 95% CI 1.00–1.26; p = 0.048).